Evonik Evonik

X

Find Deuruxolitinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Deuruxolitinib
Also known as: D8-ruxolitinib, Ctp-543, Deuruxolitinib [usan], 0ca0vsf91y, 1513883-39-0, C-21543
Molecular Formula
C17H18N6
Molecular Weight
314.41  g/mol
InChI Key
HFNKQEVNSGCOJV-FBXGHSCESA-N
FDA UNII
0CA0VSF91Y

1 2D Structure

Deuruxolitinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R)-3-(2,2,3,3,4,4,5,5-octadeuteriocyclopentyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile
2.1.2 InChI
InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1/i1D2,2D2,3D2,4D2
2.1.3 InChI Key
HFNKQEVNSGCOJV-FBXGHSCESA-N
2.1.4 Canonical SMILES
C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
2.1.5 Isomeric SMILES
[2H]C1(C(C(C(C1([2H])[2H])([2H])[2H])([2H])[2H])[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3)[2H]
2.2 Other Identifiers
2.2.1 UNII
0CA0VSF91Y
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. D8-ruxolitinib

2. Ctp-543

3. Deuruxolitinib [usan]

4. 0ca0vsf91y

5. 1513883-39-0

6. C-21543

7. Deuruxolitinib (usan)

8. (3r)-3-(2,2,3,3,4,4,5,5-octadeuteriocyclopentyl)-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile

9. Unii-0ca0vsf91y

10. Deuruxolitinib [inn]

11. Ctp543

12. Chembl4594381

13. Schembl19555526

14. Gtpl11410

15. Hy-50856s

16. Who 11622

17. Cs-0131647

18. D11866

19. (3r)-3-(2,2,3,3,4,4,5,5-d8)cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)propanenitrile

20. (3r)-3-(2,2,3,3,4,4,5,5-d8)cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1hpyrazol-1-yl)propanenitrile

21. 1h-pyrazole-1-propanenitrile, .beta.-(cyclopentyl-2,2,3,3,4,4,5,5-d8)-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (.beta.r)-

22. H-pyrazole-1-propanenitrile, Beta-(cyclopentyl-2,2,3,3,4,4,5,5-d8)-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (betar)-

2.4 Create Date
2014-01-20
3 Chemical and Physical Properties
Molecular Weight 314.41 g/mol
Molecular Formula C17H18N6
XLogP32.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass314.20950857 g/mol
Monoisotopic Mass314.20950857 g/mol
Topological Polar Surface Area83.2 Ų
Heavy Atom Count23
Formal Charge0
Complexity453
Isotope Atom Count8
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY